Skip to main content
Log in

Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder

  • Clinical Trials Report
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Horrigan JP, Barnhill LJ: Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 1995, 5:215–223.

    Article  Google Scholar 

  2. Chappell P, Riddle MA, Scahill L, et al.: Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995, 34:1140–1146.

    Article  PubMed  CAS  Google Scholar 

  3. Scahill L, Chappell P, Kim YS, et al.: A placebo controlled study of guanfacine in the treatment of children with tic disorders and attention-deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067–1074.

    Article  PubMed  CAS  Google Scholar 

  4. Taylor FB, Russo J: Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit hyperactivity disorder. J Clin Psychopharmacol 2001, 21:223–228.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony L. Rostain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rostain, A.L. Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 11, 339–340 (2009). https://doi.org/10.1007/s11920-009-0063-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-009-0063-4

Keywords

Navigation